ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria - Detection and Risk Assessment of Stable Ischemic Heart Disease

Oct 2, 2026

Uploaded by Logic

ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria address detection and risk assessment strategies for stable ischemic heart disease. The report is issued by an appropriate use criteria task force spanning major cardiovascular societies, with contributions from a multimodality writing group. It details the document’s purpose, preface, structured methods for indication development, rating process and scoring, and underlying assumptions. It also covers comparative rating, risk/benefit considerations, and contraindications.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages27

Reading Time1 h 8 min

AccessFree to download

Preface

1. Introduction

2. Methods

Indication Development

Rating Process and Scoring

3. Assumptions

General Assumptions/Considerations

Multimodality-Specific Assumptions/Considerations

Comparative Rating

Risk/Beneﬁt

Contraindications

Journal of the American College of Cardiology 􀀁 2014 by the American College of Cardiology Foundation Published by Elsevier Inc. Vol. 63, No. 4, 2014 ISSN 0735-1097/$36.00 [http://dx.doi.org/10.1016/j.jacc.2013.11.009](http://dx.doi.org/10.1016/j.jacc.2013.11.009) | |
APPROPRIATE USE CRITERIA | | | | --- | --- | --- | --- | |
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria
for the Detection and Risk Assessment of
Stable Ischemic Heart Disease | | | | | | A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography,
Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons | | | --- | --- | --- | | | | | | | | | | | | | | | | | | | | | Multimodality Writing Group for Stable Ischemic Heart Disease Michael J. Wolk, MD, MACC, Chair Steven R. Bailey, MD, FACC, FSCAI, FAHA John U. Doherty, MD, FACC, FAHA Pamela S. Douglas, MD, MACC, FAHA, FASE Robert C. Hendel, MD, FACC, FAHA, FASNC Christopher M. Kramer, MD, FACC, FAHA James K. Min, MD, FACC Manesh R. Patel, MD, FACC Lisa Rosenbaum, MD Leslee J. Shaw, PHD, FACC, FASNC, FAHA Raymond F. Stainback, MD, FACC, FASE Joseph M. Allen, MA Technical Panel Ralph G. Brindis, MD, MPH, MACC, Moderator* Christopher M. Kramer, MD, FACC, Writing Committee Liaison * Leslee J. Shaw, PhD, FACC, FASNC, FAHA, Writing Committee Liaison * Manuel D. Cerqueira, MD, FACC, FASNCy Jersey Chen, MD, FAHAz Larry S. Dean, MD, FACC, FAHA, FSCAIx Reza Fazel, MD, FACC* W. Gregory Hundley, MD, FACCk Dipti Itchhaporia, MD, FACC* Paul Kligﬁeld, MD, FACC, FAHA* Richard Lockwood, MD* Joseph Edward Marine, MD, FACC{ Robert Benjamin McCully, MD, FACC, FASE\# Joseph V. Messer, MD, MACC* Patrick T. O’Gara, MD, FACC* Richard J. Shemin, MD, FACC** L. Samuel Wann, MD, MACCyy John B. Wong, MD* This document was approved by the American College of Cardiology Foundation Board of Trustees in September 2013 . The American College of Cardiology Foundation requests that this document be cited as follows: Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM, Min JK, Patel MR, Rosenbaum L, Shaw LJ, Stainback RF, Allen JM. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2014;63:380–406. This document is copublished in the Journal of Cardiac Failure and Journal of Nuclear Cardiology. Copies: This document is available on the World Wide Web site of the American College of Cardiology ([www.acc.org](www.acc.org)). For copies of this document, please contact Elsevier Inc. Reprint Department, fax (212) 633-3820, e-mail reprints@ [elsevier.com](elsevier.com). Permissions: Modiﬁcation, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Requests may also be completed online via the Elsevier site ([http://www.elsevier.com/authors/obtainingpermission-to-re-use-elsevier-material](http://www.elsevier.com/authors/obtainingpermission-to-re-use-elsevier-material)). JACC Vol. 63, No. 4, 2014 Wolk et al. 381 Fe

FAQs

What clinical area does this document cover?

The document focuses on detection and risk assessment for stable ischemic heart disease using multimodality approaches.

How are indications and ratings developed?

It describes indication development and a rating process with scoring as part of the methods section.

What types of assumptions and evaluation factors are included?

The report outlines general and multimodality-specific assumptions, comparative rating, risk/benefit considerations, and contraindications.

Oct 2, 2026

Uploaded by Logic